Literature DB >> 26107347

Re-evaluating the New Committee on Infectious Diseases Recommendations for Palivizumab Use in Premature Infants.

Ram Yogev1, Leonard R Krilov, Jaime E Fergie, Leonard B Weiner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26107347     DOI： 10.1097/INF.0000000000000808

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  8 in total

1.  Cost-utility analysis of Palivizumab for Respiratory Syncytial Virus infection prophylaxis in preterm infants: update based on the clinical evidence in Spain.

Authors:  M Sanchez-Luna; R Burgos-Pol; I Oyagüez; J Figueras-Aloy; M Sánchez-Solís; F Martinón-Torres; X Carbonell-Estrany
Journal:  BMC Infect Dis       Date:  2017-10-17       Impact factor: 3.090

2.  Effectiveness of Palivizumab in High-risk Infants and Children: A Propensity Score Weighted Regression Analysis.

Authors:  Evan J Anderson; Phyllis Carosone-Link; Ram Yogev; Jumi Yi; Eric A F Simões
Journal:  Pediatr Infect Dis J       Date:  2017-08       Impact factor: 2.129

Review 3.  Product review on the monoclonal antibody palivizumab for prevention of respiratory syncytial virus infection.

Authors:  Bernhard Resch
Journal:  Hum Vaccin Immunother       Date:  2017-06-12       Impact factor: 3.452

Review 4.  Respiratory syncytial virus hospitalizations in US preterm infants after the 2014 change in immunoprophylaxis guidance by the American Academy of Pediatrics.

Authors:  Leonard R Krilov; Evan J Anderson
Journal:  J Perinatol       Date:  2020-06-04       Impact factor: 2.521

5.  Pediatric intensive care unit admission due to respiratory syncytial virus: Retrospective multicenter study.

Authors:  Ji-Man Kang; Jina Lee; Yun-Kyung Kim; Hye Kyung Cho; Su Eun Park; Kyung-Hyo Kim; Min-Ji Kim; Seonwoo Kim; Yae-Jean Kim
Journal:  Pediatr Int       Date:  2019-07       Impact factor: 1.524

Review 6.  Current State of Respiratory Syncytial Virus Disease and Management.

Authors:  Archana Chatterjee; Kunjana Mavunda; Leonard R Krilov
Journal:  Infect Dis Ther       Date:  2021-03-03

Review 7.  Impact of the 2014 American Academy of Pediatrics Policy on RSV Hospitalization in Preterm Infants in the United States.

Authors:  Mitchell Goldstein; Jaime Fergie; Leonard R Krilov
Journal:  Infect Dis Ther       Date:  2021-03-03

8.  The 2014-2015 National Impact of the 2014 American Academy of Pediatrics Guidance for Respiratory Syncytial Virus Immunoprophylaxis on Preterm Infants Born in the United States.

Authors:  Amanda M Kong; Leonard R Krilov; Jaime Fergie; Mitchell Goldstein; David Diakun; Sally W Wade; Melissa Pavilack; Kimmie K McLaurin
Journal:  Am J Perinatol       Date:  2017-09-07       Impact factor: 1.862
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.